analyst rating

Tech bull Dan Ives of Wedbush Securities has raised his price target for Palantir Technologies Inc. (NASDAQ:PLTR), signaling a 12% upside from its current trading price over the next 12 months. What Happened: In a post on X, Ives expressed growing confidence in Palantir's artificial intelligence...

TDR Research has recently initiated coverage of multi-state cannabis company Trulieve (OTC: TCNNF), assigning it a “Buy” rating based on an extensive analysis of the company's financial health and growth potential. The report highlights Trulieve's robust financial metrics and...

According to a recent report by Pablo Zuanic of Zuanic & Associates, MariMed (OTC: MRMD) a multi-state cannabis operator (MSO) is positioned for significant stock gains. Zuanic highlights MariMed's potential to deliver "alpha" returns, meaning returns that exceed the market...

Zuanic & Associates gave Jushi Holdings Inc. (CSE: JUSH) (OTC: JUSHF) an Overweight rating as the firm begins its coverage of the marijuana company. The analysis underscores Jushi's substantial potential within the cannabis sector, spotlighting its strategic footprint...

JPMorgan downgraded cryptocurrency exchange Coinbase (NASDAQ: COIN) to 'Underweight' while maintaining an $80 price target. The revised stance follows an "underwhelming" start to Spot Bitcoin ETF trading. What Happened: JPMorgan analysts, led by Kenneth B. Worthington, "...

Marathon Digital (NASDAQ: MARA) reported a 622.8% surge for 2023, a year that saw it acquire multiple mining sites for $179 million. The company will likely add 390 megawatts of capacity to its portfolio. The current capacity stands at 584 megawatts. The transaction is expected to close in the...

Zuanic & Associates (Z&A) initiates coverage of cannabis company MariMed (OTC: MRMD) with an Overweight rating. While the entire sector anticipates positive US federal reform news, MariMed stands out as a stock that can perform well even in the absence of such reforms....

Papa John's Int'l, Inc. (NASDAQ: PZZA) has been in focus over the past few months, with several analysts revisiting their ratings. The demand for pizza remains unchanged, with softer comps reflecting a “normalization of demand after two years of above-trend growth,” according to...

The Analyst Analyst Pablo Zuanic from Cantor Fitzgerald kept an Overweight rating for Irwin Naturals (CSE: IWIN) (OTC: IWINF) but lowered its 12-month price target to US$6.00 (C$8.05) from US$6.20 “on adjusted estimates.” The Thesis Zuanic highlighted the “potential approval...

The Analyst Columbia Care is being acquired by Cresco Labs (OTC: CRBLF), in a deal set to close by year-end. In a research note published Thursday, Cantor Fitzgerald's Pablo Zuanic kept an overweight rating for (OTC: CCHWF) with a price target of $8.37. “Due to the...

The Analyst Pablo Zuanic from Cantor Fitzgerald maintained a Neutral rating on High Tide Inc., lowering its 12-month price target to C$2.75 from C$2.80, "given the overall sectoral derating and industry challenges." "High Tide continues to consolidate the Canadian retail...

Shares of Teladoc Health Inc. (NYSE: TDOC) are trading lower today following an analyst downgrade. Why Is It Moving? Shares are down after Guggenheim downgraded the stock from Neutral to Sell and lowered its price target to $25. The firm reportedly cited slowing growth following the...

The Analyst Pablo Zuanic from Cantor Fitzgerald maintained a rating of Overweight for the stocks of Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) and lowered its price target to $54 from $57, on “slightly reduced estimates.” The Thesis In a recent analyst note, Zuanic explained why...

On Thursday, Cantor Fitzgerald analyst Pablo Zuanic offered an update on New Jersey’s recreational cannabis market. Zuanic analyzed the competitive landscape and the changes in the recreational cannabis market in The Garden State. Although the report is not a second-quarter preview, the...

Raymond James analyst Steve Hansen downgraded Canadian National Railway (NYSE: CNI) to Market Perform from Outperform with a price target of C$158, up from C$152. Hansen states that he raised the stock's target price because of the "roll-out of a new...